NICE has today (28 March) published a summary for healthcare professionals bringing together all its recommendations and other safety advice on the drug valproate.
We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
- New advice in the last 6 months (0)
- Updated advice in the last 6 months (0)
- In development advice (0)
Set out priority areas for quality improvement in health and social care.
Interactive topic-based flowcharts that allow you to navigate our recommendations on any subject.
Guidance by programme
Review the evidence across broad health and social care topics.
Reviews the clinical and cost-effectiveness of new treatments.
Review clinical and cost-effectiveness of specialised treatments.
Assessments of whether procedures are safe enough and work well enough for wider use in the NHS.
Reviews new medical devices for adoption in the NHS.
Advice by programme
Products being developed or updated
News and blogs
News on this topic
Blog on this topic
Professor May-Chahal explains how NICE guidance will help protect children and young people from abuse.
Putting guidance into practice
Examples of how our guidance and standards have been put into practice in the NHS, local authorities, voluntary sector and a range of other organisations.
Showing 3 of 64 shared learning examples for this topic:
Child abuse: communication is key
In this podcast:
Corinne May-Chahal, professor of applied science and chair of NICE guideline explains the crucial principles that need to be considered when responding to child abuse. What do young people think about this? Emma Harewood describes how we can recognise abuse and neglect and how we are moving forward in the field.